Skip to main content

ASCO Genitourinary (GU) Cancers Symposium

Oncology Data Advisor: Welcome to Oncology Data Advisor, I'm Keira Smith. Today I'm joined by Dr. Lisa Gudenkauf, who is an Applied Research Scientist in Health Outcomes and Behavior at Moffitt Cancer Center. She's here today to discuss her research regarding patient-reported outcomes for prostate cancer, which was recently presented at the ASCO Genitourinary Cancers Symposium. Dr. Gudenkauf, thank you so much for coming on today. Lisa Gudenkauf, PhD: Hi, my name is Lisa Gudenkauf. I'm an Applie...
At the recent American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, Dr. Hyma Polimera, a Hematology/Oncology Fellow at Penn State Cancer Institute, presented her research regarding COVID-19 vaccine behaviors and outcomes among patients with genitourinary cancers. In this follow-up interview, she explains the efficacy of COVID-19 vaccination among this population and shares advice for oncologists on how to counsel their patients with genitourinary cancers regarding vaccine...
Oncology Data Advisor: So, why did you decide to investigate gender disparities in National Institutes of Health funding for genitourinary oncology research? Zain Farooq, MD: Disparities exist in different fields of health care research. For example, gender disparities have recently been reported for cardiology research funding and for other fields too. That prompted us to investigate if a similar culture prevails in oncology, specifically genitourinary oncology, and we investigated that in this...
Oncology Data Advisor: So, my first question is, what prompted you to investigate patient perspectives on management of fatigue in prostate cancer? Stephen Freedland, MD: So, we've known for quite a while that fatigue is a major issue for prostate cancer patients. It can be from the cancer itself or from the therapy they are receiving, particularly the novel hormonal agents that we use. That's one of the known side effects. There has been a lot of research into understanding risk factors for fat...
Oncology Data Advisor: What prompted you to investigate the association between plant-based diets and prostate cancer disease progression? Vivian Liu: Plant-based diets are becoming increasingly popular in the United States. Market statistics show rapid growth in sales of plant-based products and a further boost during the COVID-19 pandemic. There are also reports that recommend a global shift to plant-based diets as essential to combat climate change and biodiversity loss. However, these diets ...